Episode 292 - CELMoDs in Myeloma: A Report Fr...

How is decision-making shaped in hematology? In a setting where evidence from randomized clinical trials, real-world data, and the uncertainties inherent in everyday clinical practice coexist, how do we analyze the available information to make the best treatment decisions for ou ...  Show more

Advanced Practice Providers (APPs)—including physician assistants (PAs) and nurse practitioners (NPs)—are playing an increasingly vital role in meeting the growing demand for high-quality cancer care. Corinne Shamehdi, PA-C, a hematology/oncology physician assistant and educator ...  Show more

Join host Dr. Peter Lin (Canadian Heart Research Centre, Canada) in conversation with Dr. Joel Topf (Oakland University, William Beaumont School of Medicine, USA) as they discuss how to combat CKD progression and the role of non-pharmacological vs pharmacological interventions. T ...  Show more

How will we detect disease in the future, and how might new technology aid our well-being? In this episode, Dr. Oz sits down with entrepreneur Peter Diamandis and former FDA commissioner Rob Califf inside The Vatican to uncover the truth about the future of medicine. From the lat ...  Show more

Join host, Dr. Marlies Ostermann (Guy's and St Thomas' Hospital, United Kingdom), in conversation with Dr. Javier Neyra (University of Alabama in Birmingham, United States) as they explore the role of kidney replacement therapy in managing fluid overload. They will discuss optima ...  Show more

Join KDIGO Conversations in Nephrology host, Dr. Roberto Pecoits-Filho, in conversation with Dr. Chuck Herzog as they explore the challenges that occur when managing dyskalemia. They address the consequences of hyperkalemia and hypokalemia. They also discuss how both hospitalized ...  Show more